Whole-genome sequencing can successfully identify cancer-related mutations

Whole-genome sequencing can be used to identify patients' risk for hereditary cancer, researchers have demonstrated. This is the first study that has used whole-genome sequencing to evaluate a series of 258 cancer patients' genomes to improve the ability to diagnose cancer-predisposing mutations, researchers say.

Read the whole article on Science Daily

More from Science Daily